KASINGER JAMES R. — SEC insider filings

SEC reporting owner CIK 1708172. 36 insider filings on record with FilingPulse; latest filed 2026-10-28.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-10-06 to 2026-10-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CRISPR Therapeutics AG (CRSP)General Counsel and Secretary36—22 legs · 79,192 sh · $8,506,39190

Insider filings — KASINGER JAMES R.

FiledFormIssuerReported transactionsSource
2026-10-284CRISPR Therapeutics AG (CRSP)Grant/award (A): 18,000 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2026-10-154CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,113 · Sale (S): 1,040 @ $49.26 · Option exercise (M): 2,113 (derivative)EDGAR
2026-10-084CRISPR Therapeutics AG (CRSP)Option exercise (M): 1,990 @ $13.62 · Sale (S): 1,990 @ $60.04 · Option exercise (M): 1,990 (derivative) @ $0EDGAR
2026-09-244CRISPR Therapeutics AG (CRSP)Option exercise (M): 10,400 @ $13.62 · Sale (S): 10,400 @ $60.24 · Option exercise (M): 10,400 (derivative) @ $0EDGAR
2026-06-024CRISPR Therapeutics AG (CRSP)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2026-03-244CRISPR Therapeutics AG (CRSP)Option exercise (M): 6,250 · Sale (S): 3,182 @ $46.78 · Grant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Option exercise (M): 6,250 (derivative)EDGAR
2026-03-174CRISPR Therapeutics AG (CRSP)Option exercise (M): 6,875 · Sale (S): 3,450 @ $48.26 · Option exercise (M): 6,875 (derivative)EDGAR
2026-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 5,500 · Sale (S): 2,800 @ $52.80 · Option exercise (M): 5,500 (derivative)EDGAR
2026-02-204CRISPR Therapeutics AG (CRSP)Option exercise (M): 3,825 · Sale (S): 2,112 @ $52.58 · Option exercise (M): 3,825 (derivative)EDGAR
2025-10-154CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,114 · Sale (S): 1,076 @ $66.60 · Option exercise (M): 2,114 (derivative)EDGAR
2025-10-034CRISPR Therapeutics AG (CRSP)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2025-03-244CRISPR Therapeutics AG (CRSP)Option exercise (M): 6,250 · Sale (S): 3,185 @ $41.23 · Option exercise (M): 6,250 (derivative)EDGAR
2025-03-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 36,666 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0EDGAR
2025-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 5,500 · Sale (S): 2,850 @ $42.42 · Option exercise (M): 2,250 · Sale (S): 1,116 @ $43.32 · Option exercise (M): 5,500 (derivative) · Option exercise (M): 2,250 (derivative)EDGAR
2025-02-194CRISPR Therapeutics AG (CRSP)Option exercise (M): 20,000 · Sale (S): 9,595 @ $53.85 · Option exercise (M): 3,825 · Sale (S): 1,947 @ $52.80 · Option exercise (M): 20,000 (derivative) · Option exercise (M): 3,825 (derivative)EDGAR
2024-10-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 18,333 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-10-154CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,113 · Sale (S): 1,089 @ $46.28 · Option exercise (M): 2,113 (derivative)EDGAR
2024-03-224CRISPR Therapeutics AG (CRSP)Grant/award (A): 33,333 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 5,500 · Sale (S): 2,801 @ $78.26 · Option exercise (M): 2,250 · Sale (S): 1,146 @ $74.44 · Option exercise (M): 5,500 (derivative) · Option exercise (M): 2,250 (derivative)EDGAR
2024-02-214CRISPR Therapeutics AG (CRSP)Option exercise (M): 3,825 · Sale (S): 1,913 @ $79.67 · Option exercise (M): 3,825 (derivative)EDGAR
2023-10-174CRISPR Therapeutics AG (CRSP)Grant/award (A): 16,667 (derivative) @ $0 · Grant/award (A): 6,340 (derivative) @ $0EDGAR
2023-03-144CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,833 · Tax withholding (F): 1,283 @ $43.22 · Option exercise (M): 2,250 · Tax withholding (F): 1,022 @ $43.22 · Option exercise (M): 2,833 (derivative) · Grant/award (A): 40,000 (derivative) @ $0 · +2 moreEDGAR
2023-02-224CRISPR Therapeutics AG (CRSP)Option exercise (M): 3,825 · Tax withholding (F): 1,950 @ $48.26 · Option exercise (M): 3,825 (derivative)EDGAR
2022-12-064CRISPR Therapeutics AG (CRSP)Option exercise (M): 6,667 · Tax withholding (F): 3,234 @ $52.26 · Option exercise (M): 6,667 (derivative)EDGAR
2022-10-124CRISPR Therapeutics AG (CRSP)Grant/award (A): 14,000 (derivative) @ $0EDGAR
2022-08-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-03-144CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,834 · Tax withholding (F): 1,321 @ $62.56 · Option exercise (M): 2,250 · Tax withholding (F): 1,039 @ $61.08 · Option exercise (M): 2,834 (derivative) · Option exercise (M): 2,250 (derivative)EDGAR
2022-02-224CRISPR Therapeutics AG (CRSP)Grant/award (A): 34,200 (derivative) @ $0 · Grant/award (A): 15,300 (derivative) @ $0EDGAR
2021-12-074CRISPR Therapeutics AG (CRSP)Option exercise (M): 13,333 · Tax withholding (F): 6,303 @ $69.17 · Option exercise (M): 13,333 (derivative)EDGAR
2021-12-034CRISPR Therapeutics AG (CRSP)Option exercise (M): 7,342 @ $13.62 · Option exercise (M): 7,342 (derivative) @ $0EDGAR
2021-10-184CRISPR Therapeutics AG (CRSP)Grant/award (A): 10,800 (derivative) @ $0EDGAR
2021-09-144CRISPR Therapeutics AG (CRSP)Option exercise (M): 10,000 · Tax withholding (F): 4,741 @ $117.86 · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-03-124CRISPR Therapeutics AG (CRSP)Option exercise (M): 2,833 · Tax withholding (F): 1,353 @ $124.15 · Grant/award (A): 25,360 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2021-01-204CRISPR Therapeutics AG (CRSP)Option exercise (M): 27,500 @ $51.49 · Sale (S): 6,785 @ $203.58 · Sale (S): 7,818 @ $204.40 · Sale (S): 8,997 @ $205.60 · Sale (S): 1,800 @ $206.05 · Sale (S): 2,100 @ $207.61 · +1 moreEDGAR
2020-12-104CRISPR Therapeutics AG (CRSP)Option exercise (M): 22,026 @ $13.62 · Option exercise (M): 22,026 (derivative) @ $0EDGAR
2020-10-064CRISPR Therapeutics AG (CRSP)Grant/award (A): 11,666 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1708172 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs